[HTML][HTML] CDK inhibitors in cancer therapy, an overview of recent development

M Zhang, L Zhang, R Hei, X Li, H Cai… - American journal of …, 2021 - ncbi.nlm.nih.gov
Dysregulated cell division, which leads to aberrant cell proliferation, is one of the key
hallmarks of cancer. Therefore, therapeutic targets that block cell division would be effective …

Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies

P Sharma, P Srivastava, A Seth, PN Tripathi… - Progress in …, 2019 - Elsevier
AD is a progressive neurodegenerative disorder and a leading cause of dementia in an
aging population worldwide. The enormous challenge which AD possesses to global …

Targeting CDK1 in cancer: mechanisms and implications

Q Wang, AM Bode, T Zhang - NPJ precision oncology, 2023 - nature.com
Cyclin dependent kinases (CDKs) are serine/threonine kinases that are proposed as
promising candidate targets for cancer treatment. These proteins complexed with cyclins …

GSK-3β, a pivotal kinase in Alzheimer disease

M Llorens-Marítin, J Jurado, F Hernández… - Frontiers in molecular …, 2014 - frontiersin.org
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …

Alzheimer's disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment

P dos Santos, C Leide, PF Ozela… - Current medicinal …, 2018 - ingentaconnect.com
Dementia is characterized by the impairment of cognition and behavior of people over 65
years. Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in the …

Tau protein kinases: involvement in Alzheimer's disease

L Martin, X Latypova, CM Wilson, A Magnaudeix… - Ageing research …, 2013 - Elsevier
Tau phosphorylation is regulated by a balance between tau kinase and phosphatase
activities. Disruption of this equilibrium was suggested to be at the origin of abnormal tau …

Neurodegenerative tauopathies

VMY Lee, M Goedert… - Annual review of …, 2001 - annualreviews.org
▪ Abstract The defining neuropathological characteristics of Alzheimer's disease are
abundant filamentous tau lesions and deposits of fibrillar amyloid β peptides. Prominent …

GSK-3: tricks of the trade for a multi-tasking kinase

BW Doble, JR Woodgett - Journal of cell science, 2003 - journals.biologists.com
Glycogen synthase kinase 3 (GSK-3) is a multifunctional serine/threonine kinase found in all
eukaryotes. The enzyme is a key regulator of numerous signalling pathways, including …

The multifaceted roles of glycogen synthase kinase 3β in cellular signaling

CA Grimes, RS Jope - Progress in neurobiology, 2001 - Elsevier
Glycogen synthase kinase-3β (GSK3β) is a fascinating enzyme with an astoundingly diverse
number of actions in intracellular signaling systems. GSK3β activity is regulated by serine …

The specificities of protein kinase inhibitors: an update

J Bain, H McLauchlan, M Elliott, P Cohen - Biochemical Journal, 2003 - portlandpress.com
We have previously examined the specificities of 28 commercially available compounds,
reported to be relatively selective inhibitors of particular serine/threonine-specific protein …